ATE105842T1 - Von thrombin abstammende polypeptid- zusammensetzungen und methoden für ihre benutzung. - Google Patents
Von thrombin abstammende polypeptid- zusammensetzungen und methoden für ihre benutzung.Info
- Publication number
- ATE105842T1 ATE105842T1 AT87907652T AT87907652T ATE105842T1 AT E105842 T1 ATE105842 T1 AT E105842T1 AT 87907652 T AT87907652 T AT 87907652T AT 87907652 T AT87907652 T AT 87907652T AT E105842 T1 ATE105842 T1 AT E105842T1
- Authority
- AT
- Austria
- Prior art keywords
- thrombin
- receptor
- occupancy
- signals
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/925,201 US5352664A (en) | 1986-10-31 | 1986-10-31 | Thrombin derived polypeptides; compositions and methods for use |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE105842T1 true ATE105842T1 (de) | 1994-06-15 |
Family
ID=25451374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT87907652T ATE105842T1 (de) | 1986-10-31 | 1987-10-30 | Von thrombin abstammende polypeptid- zusammensetzungen und methoden für ihre benutzung. |
Country Status (7)
Country | Link |
---|---|
US (3) | US5352664A (de) |
EP (1) | EP0328552B2 (de) |
JP (1) | JP3054150B2 (de) |
AT (1) | ATE105842T1 (de) |
AU (1) | AU8239987A (de) |
DE (1) | DE3789870T3 (de) |
WO (1) | WO1988003151A2 (de) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6630572B1 (en) | 1986-10-31 | 2003-10-07 | The Board Of Regents, University Of Texas Syatems | Thrombin derived polypeptides: compositions and methods for use |
ZW6189A1 (en) * | 1988-05-09 | 1990-05-09 | Smithkline Beckman Corp | Anti-aggregatory peptides |
CA2006060A1 (en) * | 1988-12-20 | 1990-06-20 | Michael D. Pierschbacher | Polypeptide-polymer conjugates active in wound healing |
US5654267A (en) * | 1988-12-20 | 1997-08-05 | La Jolla Cancer Research Center | Cooperative combinations of ligands contained within a matrix |
US5120829A (en) * | 1989-03-20 | 1992-06-09 | La Jolla Cancer Research Foundation | Hydrophobic attachment site for adhesion peptides |
US5795867A (en) * | 1989-06-16 | 1998-08-18 | Cor Therapeutics, Inc. | Platelet aggregation inhibitors |
US5770564A (en) * | 1989-06-16 | 1998-06-23 | Cor Therapeutics, Inc. | Platelet aggregation inhibitors |
US5318899A (en) * | 1989-06-16 | 1994-06-07 | Cor Therapeutics, Inc. | Platelet aggregation inhibitors |
US7214375B1 (en) | 1989-09-29 | 2007-05-08 | La Jolla Cancer Research Foundation | Methods of decreasing the accumulation of extracellular matrix associated with glomerulonephritis with anti-TGF-β-specific antibodies |
AU654938B2 (en) * | 1989-09-29 | 1994-12-01 | La Jolla Cancer Research Foundation | Inhibiting transforming growth factor beta to prevent accumulation of extracellular matrix |
US5672585A (en) * | 1990-04-06 | 1997-09-30 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5612311A (en) * | 1990-04-06 | 1997-03-18 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5780303A (en) * | 1990-04-06 | 1998-07-14 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US6521594B1 (en) | 1990-04-06 | 2003-02-18 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US7119182B1 (en) | 1991-02-19 | 2006-10-10 | The Regents Of The University Of California | Recombinant thrombin receptor and related pharmaceuticals |
ATE179074T1 (de) * | 1991-11-07 | 1999-05-15 | Univ Southern California | Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung |
JPH07507995A (ja) * | 1992-03-02 | 1995-09-07 | バイオジェン,インコーポレイテッド | トロンビンレセプターアンタゴニスト |
DK83092D0 (da) * | 1992-06-24 | 1992-06-24 | Unes As | Fremgangsmaade til udvinding af thrombin |
IL106197A (en) * | 1992-07-30 | 1999-11-30 | Cor Therapeutics Inc | Agagonists for the rhombin receptors and pharmaceutical preparations containing them |
US5516889A (en) * | 1993-06-21 | 1996-05-14 | University Technologies International, Inc. | Synthetic thrombin receptor peptides |
US5795780A (en) * | 1993-06-23 | 1998-08-18 | Bristol-Myers Squibb Company | Method of use of autologous thrombin blood fraction in a cell culture with keratinocytes |
US5716789A (en) * | 1993-07-26 | 1998-02-10 | Cor Therapeutics, Inc. | Method to determine ligands, agonist and antagonist of C140 receptor |
US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
US7060484B1 (en) | 1993-11-12 | 2006-06-13 | Gilead Sciences, Inc. | Polypeptides and coagulation therapy |
DE69434332T2 (de) * | 1993-11-12 | 2006-02-02 | Gilead Sciences, Inc., Foster City | Thrombin mutanten |
FR2722509B1 (fr) * | 1994-07-15 | 1996-09-20 | Pasteur Institut | Identification de genes codant pour des proteines ayant une activite d'esterase dans differentes souches de mycoplasma mycoides |
IL114140A (en) * | 1995-06-14 | 2000-06-01 | Hadasit Med Res Service | Anti-metastatic and anti-angiogenetic pharmaceutical compositions |
IL114890A (en) * | 1995-08-10 | 1999-08-17 | Hadasit Med Res Service | Method and kits for evaluating the metastatic tendency of tumor cells |
US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
US6274090B1 (en) | 1998-08-05 | 2001-08-14 | Thermogenesis Corp. | Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
IL125698A (en) * | 1998-08-07 | 2007-03-08 | Hadasit Med Res Service | Use of molecules associated with protease activated receptors for the preparation of pharmaceutical compositions and pharmaceutical compositions comprising them |
IL127174A0 (en) | 1998-11-20 | 1999-09-22 | Almog Projects Ltd | Sewage treatment facility and method |
US7261881B1 (en) | 1999-05-20 | 2007-08-28 | Yale University | Modulation of angiogenesis and wound healing |
US6472162B1 (en) | 1999-06-04 | 2002-10-29 | Thermogenesis Corp. | Method for preparing thrombin for use in a biological glue |
US7053043B1 (en) * | 1999-07-23 | 2006-05-30 | Yeda Research And Development Co.Ltd. | Pharmaceutical compositions comprising synthetic peptide copolymers and methods for preventing and treating GVHD and HVGD |
US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
GB9925005D0 (en) * | 1999-10-22 | 1999-12-22 | Univ Nottingham | The treatment of wounds |
TWI257307B (en) * | 2000-07-12 | 2006-07-01 | Orthologic Corp | Pharmaceutical composition for cardiac tissue repair |
AU7697701A (en) * | 2000-07-19 | 2002-01-30 | Univ Texas | Stimulation of bone growth with thrombin peptide derivatives |
AU2001273561B2 (en) * | 2000-07-20 | 2004-10-28 | Orthologic Corp. | Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
CN100509055C (zh) * | 2001-07-27 | 2009-07-08 | 奥索洛吉艾斯有限公司 | 使用凝血酶衍生的缩氨酸治疗慢性真皮溃疡 |
CA2511223A1 (en) * | 2002-01-16 | 2003-07-31 | The Board Of Regents, The University Of Texas System | Thrombin derived peptides for promoting cardiac tissue repair |
EP1539214A4 (de) * | 2002-07-02 | 2008-01-02 | Orthologic Corp | Thrombinpeptidderivate |
WO2004005317A2 (en) * | 2002-07-02 | 2004-01-15 | The Board Of Regents, The University Of Texas System | Thrombin peptide derivative dimers |
US20080019955A1 (en) * | 2003-12-30 | 2008-01-24 | Bioactive Polymers Ab | Surface Protection of Exposed Biological Tissues |
SE0303588D0 (sv) | 2003-12-30 | 2003-12-30 | Bioactive Polymers Ab C O Lund | Surface protection of exposed biological tissues |
EP1559431B1 (de) * | 2003-12-31 | 2007-03-28 | Orthologic Corp. | Pharmazeutische Zusammensetzung für Thrombinpeptidderivaten |
CA2558014A1 (en) | 2004-03-12 | 2005-09-29 | Entremed, Inc. | Antiangiogenic agents |
US7795205B2 (en) * | 2004-04-12 | 2010-09-14 | Canyon Pharmaceuticals, Inc. | Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor |
EP1778652A2 (de) * | 2004-08-20 | 2007-05-02 | EntreMed, Inc. | Zusammensetzungen und verfahren mit proteinaseaktivierten rezeptorantagonisten |
US20070275874A1 (en) * | 2004-09-03 | 2007-11-29 | Yale University | Use of Leptin in Wound Healing |
US7935341B2 (en) * | 2005-09-16 | 2011-05-03 | Orthologic Corp. | Antibodies to complementary peptides of thrombin or portions thereof |
US8399440B2 (en) | 2006-03-20 | 2013-03-19 | Entremed, Inc. | Disease modifying anti-arthritic activity of 2-methoxyestradiol |
US20080039362A1 (en) * | 2006-08-09 | 2008-02-14 | Afmedica, Inc. | Combination drug therapy for reducing scar tissue formation |
CA2663547C (en) * | 2006-09-22 | 2020-08-25 | Orthologic Corp. | Method of treating endothelial dysfunction |
EP2155234A1 (de) * | 2007-04-10 | 2010-02-24 | The Board of Regents,The University of Texas System | Kombinationstherapie gegen chronische hautgeschwüre |
US8952129B2 (en) * | 2008-03-26 | 2015-02-10 | The Board Of Regents Of The University Of Texas System | Method of treating degenerative diseases |
AU2009229399A1 (en) * | 2008-03-26 | 2009-10-01 | Orthologic Corp. | Thrombin derived peptides for smooth muscle relaxation |
US20110110920A1 (en) * | 2008-03-26 | 2011-05-12 | Orthologic Corp. | Method of treating peripheral arterial disease |
WO2009142679A2 (en) * | 2008-03-26 | 2009-11-26 | Orthologic Corp. | Methods for treating acute myocardial infarction |
WO2010033862A2 (en) * | 2008-09-19 | 2010-03-25 | The Board Of Regents, The University Of Texas System | Methods for treating cancer |
KR101297037B1 (ko) * | 2010-03-26 | 2013-08-14 | 숙명여자대학교산학협력단 | 혈관신생촉진용 펩타이드 및 이의 용도 |
US20130101574A1 (en) * | 2010-06-11 | 2013-04-25 | Darrell H. Carney | Methods of using thrombin peptide derivatives |
CA2802176A1 (en) | 2010-06-11 | 2011-12-15 | The Board Of Regents, The University Of Texas System | Methods of mitigating effects of radiation and reducing the risk of systemic infection |
US10220078B2 (en) * | 2014-06-11 | 2019-03-05 | The Board Of Regents Of The University Of Texas System | Methods of using thrombin derivatives to treat medulloblastoma |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE13810T1 (de) * | 1981-06-25 | 1985-07-15 | Serapharm Gmbh & Co Kg | Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundabdeckung. |
DE3214337C2 (de) * | 1982-04-19 | 1984-04-26 | Serapharm - Michael Stroetmann, 4400 Münster | Resorbierbares Flachmaterial zum Abdichten und Heilen von Wunden und Verfahren zu dessen Herstellung |
US4578079A (en) * | 1982-08-04 | 1986-03-25 | La Jolla Cancer Research Foundation | Tetrapeptide |
US4515637A (en) * | 1983-11-16 | 1985-05-07 | Seton Company | Collagen-thrombin compositions |
US4988621A (en) | 1985-05-24 | 1991-01-29 | La Jolla Cancer Research Foundation | Peptides in cell detachment and aggregation |
US4683291A (en) * | 1985-10-28 | 1987-07-28 | Scripps Clinic And Research Foundation | Platelet binding inhibitors |
-
1986
- 1986-10-31 US US06/925,201 patent/US5352664A/en not_active Expired - Lifetime
-
1987
- 1987-10-30 AU AU82399/87A patent/AU8239987A/en not_active Abandoned
- 1987-10-30 DE DE3789870T patent/DE3789870T3/de not_active Expired - Lifetime
- 1987-10-30 JP JP62507053A patent/JP3054150B2/ja not_active Expired - Lifetime
- 1987-10-30 WO PCT/US1987/002882 patent/WO1988003151A2/en active IP Right Grant
- 1987-10-30 EP EP87907652A patent/EP0328552B2/de not_active Expired - Lifetime
- 1987-10-30 AT AT87907652T patent/ATE105842T1/de not_active IP Right Cessation
-
1993
- 1993-01-21 US US08/007,173 patent/US5500412A/en not_active Expired - Lifetime
-
1995
- 1995-09-29 US US08/538,504 patent/US6627731B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE3789870T2 (de) | 1994-09-01 |
EP0328552A1 (de) | 1989-08-23 |
WO1988003151A3 (en) | 1988-07-28 |
US5500412A (en) | 1996-03-19 |
JPH02501028A (ja) | 1990-04-12 |
JP3054150B2 (ja) | 2000-06-19 |
DE3789870T3 (de) | 1997-10-02 |
DE3789870D1 (de) | 1994-06-23 |
US6627731B1 (en) | 2003-09-30 |
EP0328552B2 (de) | 1997-05-02 |
WO1988003151A2 (en) | 1988-05-05 |
US5352664A (en) | 1994-10-04 |
AU8239987A (en) | 1988-05-25 |
EP0328552B1 (de) | 1994-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE105842T1 (de) | Von thrombin abstammende polypeptid- zusammensetzungen und methoden für ihre benutzung. | |
DE68929043T2 (de) | Für androgen-rezeptor-protein kodierende dna | |
PT917571E (pt) | Gene relacionado com agouti | |
DE69029657T2 (de) | Menschliches cytokin, interleukin-9 | |
ATE442373T1 (de) | Nukleotid- und proteinsequenzen von delta-genen von vertebraten und darauf basierende methoden | |
ATE458050T1 (de) | Promotion oder inhibition von angiogenese und kardiovaskularisation | |
DE69824597D1 (de) | Ikk-beta proteine, nukleinsäuren und verfahren | |
DE69840387D1 (de) | Nik proteine, nukleinsäure sowie verfahren | |
CY1109518T1 (el) | Αναστολεας ενεργοποιητη αυξητικου παραγοντα ηπατοκυτταρων για χρηση σε διαμορφωση αγγειογενεσης και καρδιοαγγειωσης | |
NZ503235A (en) | Amino-terminally truncated RANTES as chemokine antagonists | |
DE69435020D1 (en) | Protein-tyrosin-phosphatase ptp-s31 | |
DE68917837D1 (de) | Peptid-Verbindungen. | |
CA2227046A1 (en) | Peptides for use in wound treatment | |
ATE363488T1 (de) | Zusammensetzungen von stammzellfaktor (scf)- analogen und auf diese bezogene verfahren | |
DE59712235D1 (de) | Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe | |
DE59105231D1 (de) | Klonierung und Überexpression von Glucose-6-Phosphat-Dehydrogenase aus Leuconostoc dextranicus. | |
DE60038740D1 (de) | Stimulierung oder hemmung von angiogenese und herzvaskularisierung | |
DE69615185T2 (de) | Faktor ix bindende peptide abgeleitet von faktor vii und ihre verwendung als inhibitoren der blutgerinnung | |
KR880701073A (ko) | 제조합 dna 기법에 의해 생성된 민악티빈 | |
EP0312283A3 (de) | Di- oder Tripeptid-Renin-Inhibitoren, die Lactam-Konformationsrestriktion in ACHPA enthalten | |
Banaś-Gruszka et al. | Activation of duck prothrombin by factor Xa and thrombin | |
EP0314239A3 (de) | Tripeptid-Renin-Inhibitoren mit N-terminalen Ureid- oder Sulfamid-Gruppen | |
EP0312291A3 (de) | Di- oder Tripeptid-Renin-Inhibitoren, die eine Lactam-Konformationsrestriktion in ACHPA enthalten | |
EP0218432A3 (de) | Verfahren zur Klonierung von cDNS und darin zu verwendende Vektor-Primär-DNS, Plasmid-DNS und Verknüpfungs-DNS | |
MX9504057A (es) | Proteina que tiene actividad tpo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |